[HTML][HTML] Euglycemic diabetic ketoacidosis: A missed diagnosis
P Nasa, S Chaudhary, PK Shrivastava… - World journal of …, 2021 - ncbi.nlm.nih.gov
Euglycemic diabetic ketoacidosis (DKA) is an acute life-threatening metabolic emergency
characterized by ketoacidosis and relatively lower blood glucose (less than 11 mmol/L). The …
characterized by ketoacidosis and relatively lower blood glucose (less than 11 mmol/L). The …
[HTML][HTML] Sodium-glucose co-transporter 2 inhibitor-associated euglycemic diabetic ketoacidosis after bariatric surgery: a case and literature review
V Kapila, J Topf - Cureus, 2021 - ncbi.nlm.nih.gov
Abstract Sodium-glucose cotransporter-2 inhibitors (SGLT2i) reduce cardiovascular, kidney,
and overall mortality. SGLT2i are also associated with a rare adverse event, euglycemic …
and overall mortality. SGLT2i are also associated with a rare adverse event, euglycemic …
SGLT-2 inhibitors associated euglycemic and hyperglycemic DKA in a multicentric cohort
Euglycemic diabetic ketoacidosis (EuDKA) secondary to Sodium-glucose co-transporter-2
inhibitors (SGLT2i) in type 2 diabetes mellitus (T2D) is a rare but increasingly reported …
inhibitors (SGLT2i) in type 2 diabetes mellitus (T2D) is a rare but increasingly reported …
Sodium-glucose co-transporter-2 inhibitors induced diabetic ketoacidosis in patients undergoing bariatric surgery: a systematic review of case reports and case series
N Gokhare Viswanath, M Sharma, N Bandlamudi, I Idris… - Obesity Surgery, 2023 - Springer
Abstract Sodium-glucose co-transporter-2 inhibitors (SGLT2i) are glucose-lowering agents
being increasingly used for cardio-renal protection in patients with or without type 2 diabetes …
being increasingly used for cardio-renal protection in patients with or without type 2 diabetes …
A low-carbohydrate diet improves glucose metabolism in lean insulinopenic Akita mice along with sodium-glucose cotransporter 2 inhibitor
Y Fujita, KK Atageldiyeva, Y Takeda… - Frontiers in …, 2020 - frontiersin.org
Objective A low-carbohydrate diet (LC) can be beneficial to obese subjects with type2
diabetes mellitus (T2DM). Sodium-glucose cotransporter 2 inhibitor (SGLT2i) presents …
diabetes mellitus (T2DM). Sodium-glucose cotransporter 2 inhibitor (SGLT2i) presents …
Very low carbohydrate ketogenic diets and diabetes
P Dyson - Practical Diabetes, 2020 - Wiley Online Library
Very low carbohydrate ketogenic diets (VLCKD) have been widely promoted for the
management of diabetes. There is confusion among people with diabetes and health …
management of diabetes. There is confusion among people with diabetes and health …
[HTML][HTML] Dietary Changes Leading to Euglycemic Diabetic Ketoacidosis in Sodium-Glucose Cotransporter-2 Inhibitor Users: A Challenge for Primary Care Physicians?
MKR Somagutta, U Uday, N Shama… - Korean Journal of …, 2022 - ncbi.nlm.nih.gov
Background The use of euglycemic diabetic ketoacidosis (EDKA) related to sodium-glucose
cotransporter 2 inhibitors (SGLT2i) use in people with diabetes has been increasingly …
cotransporter 2 inhibitors (SGLT2i) use in people with diabetes has been increasingly …
[HTML][HTML] Sodium-glucose linked transporter inhibitors as a cause of euglycemic diabetic ketoacidosis on a background of starvation
We present a case of a male diabetic patient with one of the most well-known major
complications of diabetes mellitus (DM), ie, diabetic ketoacidosis (DKA). The finding of …
complications of diabetes mellitus (DM), ie, diabetic ketoacidosis (DKA). The finding of …
Euglycaemic diabetic ketoacidosis in a 43-year-old woman with type 2 diabetes mellitus on SGLT-2 inhibitor (empagliflozin)
A Latif, AA Gastelum, A Sood… - BMJ Case Reports …, 2020 - casereports.bmj.com
We report a case of euglycaemic diabetic ketoacidosis (EDKA) in a 43-year-old woman with
type 2 diabetes mellitus who presented to the emergency department with problems of …
type 2 diabetes mellitus who presented to the emergency department with problems of …
Tubular injury causing protracted glycosuria following withdrawal of a sodium-glucose cotransporter 2 (SGLT2) inhibitor: a possible role in the development of …
R Hashi, N Fujiki, T Yagi - The Tohoku Journal of Experimental …, 2021 - jstage.jst.go.jp
We herein present the case of a 45-year-old diabetic woman who developed diabetic
ketoacidosis following the administration of dapagliflozin, a sodium-glucose cotransporter 2 …
ketoacidosis following the administration of dapagliflozin, a sodium-glucose cotransporter 2 …